T. Waterhouse

Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients

J. Henck, V. Krishnan, C. Benson, 2018, Andrology.

A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

Stefanie Hennig, Stephen B Duffull, Hugh Miller, 2007, British journal of clinical pharmacology.

Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients

Stephen B. Duffull, John A. Eccleston, Stefanie Redmann, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

J. Tabernero, D. Melisi, A. Cleverly, 2019, Cancer Chemotherapy and Pharmacology.

Optimal Design Criteria for Discrimination and Estimation in Nonlinear Models

S B Duffull, T H Waterhouse, J A Eccleston, 2009, Journal of biopharmaceutical statistics.

Optimal Crossover Designs for Logistic Regression Models in Pharmacodynamics

S B Duffull, J A Eccleston, J. Eccleston, 2006, Journal of biopharmaceutical statistics.

Some Considerations on the Design of Population Pharmacokinetic Studies

Stephen Duffull, Tim Waterhouse, John Eccleston, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

J Snoeys, S D Hall, L Zhang, 2014, Clinical pharmacology and therapeutics.

Population Pharmacokinetics of LY2623091 in Patients With Hypertension and Chronic Kidney Disease

G. Dickinson, Evan B. Wang, A. Chaudhary, 2017, Journal of clinical pharmacology.

The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins

K. Krueger, J. Kastelein, S. Friedrich, 2014, CPT: pharmacometrics & systems pharmacology.